v1
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.
Identifier:nobleid.org/w1/20260515/4880F2AC
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/4880F2AC)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims